Sale!

COG8 Gene Glycosylation Disorder Type 2H Genetic Test

Original price was: $700.Current price is: $500.

-29%

The COG8 Gene Glycosylation Disorder Type 2H NGS Genetic DNA Test is a cutting-edge diagnostic tool that identifies mutations in the COG8 gene responsible for congenital disorders of glycosylation. This comprehensive test utilizes next-generation sequencing technology to detect specific genetic variations that disrupt protein glycosylation processes, leading to metabolic disorders. Patients experiencing developmental delays, neurological symptoms, or unexplained metabolic abnormalities should consider this test. The analysis provides crucial information for accurate diagnosis, personalized treatment planning, and genetic counseling. Available for only $500 USD, this test offers significant savings from the regular $700 USD price. Early detection enables proactive management and improved quality of life for affected individuals and their families.

Trusted Testing. Expert Care. Guaranteed Privacy.

  • Accredited and Trusted
  • Expert Scientists, Advanced Technology
  • Data Privacy Guaranteed
Guaranteed Safe Checkout

COG8 Gene Glycosylation Disorder Type 2H NGS Genetic DNA Test

Comprehensive Introduction to COG8 Genetic Testing

The COG8 Gene Glycosylation Disorder Type 2H NGS Genetic DNA Test represents a breakthrough in metabolic disorder diagnostics. This advanced genetic screening utilizes next-generation sequencing (NGS) technology to identify mutations in the COG8 gene, which plays a critical role in the conserved oligomeric Golgi (COG) complex. This complex is essential for proper protein glycosylation – the process of adding sugar molecules to proteins, which is fundamental for cellular function, protein stability, and intercellular communication.

Glycosylation disorders, particularly Type 2H caused by COG8 mutations, represent rare but serious congenital conditions that can significantly impact multiple organ systems. Early and accurate diagnosis through this specialized genetic test enables healthcare providers to implement targeted interventions, manage symptoms effectively, and provide comprehensive genetic counseling for affected families.

What the Test Measures and Detects

This sophisticated genetic analysis specifically targets:

  • Complete sequencing of the COG8 gene to identify pathogenic variants
  • Detection of missense, nonsense, frameshift, and splice-site mutations
  • Identification of both inherited and de novo genetic alterations
  • Assessment of variant pathogenicity using advanced bioinformatics tools
  • Comprehensive analysis of glycosylation-related genetic markers

The test employs state-of-the-art NGS technology, providing unparalleled accuracy in detecting even the most subtle genetic variations that conventional methods might miss. This comprehensive approach ensures reliable results for clinical decision-making and family planning.

Who Should Consider This Genetic Test

Clinical Indications and Symptoms

This test is particularly recommended for individuals presenting with:

  • Unexplained developmental delays in infancy or childhood
  • Neurological symptoms including seizures, hypotonia, or ataxia
  • Failure to thrive and growth retardation
  • Hepatic dysfunction or abnormal liver function tests
  • Coagulation abnormalities and bleeding tendencies
  • Dysmorphic facial features associated with metabolic disorders
  • Family history of glycosylation disorders or unexplained infant mortality
  • Abnormal carbohydrate-deficient transferrin (CDT) test results

Special Considerations

Genetic counseling is strongly recommended before testing, especially for:

  • Couples with a family history of metabolic disorders planning pregnancy
  • Parents of children with suspected congenital disorders of glycosylation
  • Individuals with siblings affected by similar metabolic conditions

Significant Benefits of COG8 Genetic Testing

Undergoing this comprehensive genetic analysis provides numerous advantages:

  • Accurate Diagnosis: Precise identification of COG8 mutations enables definitive diagnosis, eliminating diagnostic uncertainty
  • Personalized Treatment: Results guide targeted therapeutic interventions and management strategies
  • Family Planning: Provides crucial information for reproductive decision-making and prenatal testing options
  • Prognostic Information: Helps predict disease progression and potential complications
  • Early Intervention: Facilitates timely implementation of supportive care and monitoring protocols
  • Research Contribution: Participation advances scientific understanding of rare metabolic disorders

Understanding Your Test Results

Interpretation Guidelines

Your genetic test results will be carefully interpreted by our team of certified genetic specialists:

  • Positive Result: Indicates the presence of pathogenic COG8 mutations confirming Glycosylation Disorder Type 2H diagnosis
  • Negative Result: Suggests absence of detectable COG8 mutations, though other genetic causes should be considered
  • Variant of Uncertain Significance (VUS): Identifies genetic changes with unclear clinical implications requiring further evaluation
  • Carrier Status: Determines if an individual carries one copy of a mutated gene without showing symptoms

Post-Test Recommendations

Following result disclosure, our genetic counseling team provides:

  • Comprehensive explanation of findings and their clinical implications
  • Personalized management recommendations based on genetic results
  • Family testing guidance and recurrence risk assessment
  • Referrals to appropriate specialists for ongoing care
  • Support resources and patient education materials

Test Pricing and Availability

Price Type Amount (USD)
Discount Price $500
Regular Price $700

Test Specifications

  • Turnaround Time: 3 to 4 Weeks
  • Sample Type: Blood, Extracted DNA, or One Drop Blood on FTA Card
  • Methodology: Next-Generation Sequencing (NGS) Technology
  • Specialty: Metabolic Genetics
  • Department: Genetics

Pre-Test Requirements

Before testing, please ensure:

  • Complete clinical history of the patient
  • Genetic counseling session to create a detailed family pedigree
  • Documentation of affected family members with glycosylation disorders
  • Informed consent for genetic testing

Nationwide Testing Availability

We proudly offer comprehensive genetic testing services across the United States, with convenient locations in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Our network of certified collection centers ensures accessible testing for patients nationwide.

Take Action Today

Don’t let uncertainty about metabolic symptoms delay proper diagnosis and treatment. Our experienced genetic specialists are ready to guide you through the testing process and provide the answers you need for informed healthcare decisions.

Call or WhatsApp us today at +1(267) 388-9828 to schedule your COG8 Gene Glycosylation Disorder Type 2H NGS Genetic DNA Test. Our compassionate team will assist with appointment scheduling, insurance verification, and answer any questions about the testing process.

Early genetic testing can make a significant difference in managing metabolic disorders effectively. Take the first step toward clarity and personalized care by booking your test today.